Emergent Biosolutions (EBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EBS | AMGN | GILD | VRTX | BIIB |
| Company | Emergent Biosolutions | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Biogen Inc |
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 2.0100 | 265.72 | 65.50 | 393.52 | 201.22 |
| High | 2.0100 | 271.68 | 66.35 | 398.60 | 207.33 |
| Low | 1.9250 | 265.72 | 64.63 | 393.49 | 199.10 |
| Last | 1.9300 | 269.74 | 65.63 | 398.85 | 206.69 |
| Change | -0.0200 | +0.36 | +0.36 | +1.15 | +4.23 |
| % Change | -1.03% | +0.13% | +0.55% | +0.29% | +2.09% |
| Volume | 307,062 | 357,517 | 4,500,776 | 147,732 | 434,871 |
| 20-Day Average Volume | 985,255 | 2,050,966 | 6,642,376 | 916,140 | 1,201,308 |
| Previous Close | 1.9500 | 269.38 | 65.27 | 397.70 | 202.46 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.1318 | 269.98 | 68.29 | 401.32 | 201.01 |
| 20-Day Raw Stochastic | 14.63% | 39.35% | 9.78% | 23.96% | 65.56% |
| 20-Day Relative Strength | 42.62% | 45.29% | 29.51% | 43.25% | 47.66% |
| Weighted Alpha | -84.20 | +9.36 | -23.41 | +15.11 | -32.63 |
| Today's Opinion | 72% Sell | 72% Sell | 100% Sell | 8% Buy | 88% Sell |
| Previous Opinion | 72% Sell | 72% Sell | 100% Sell | 8% Buy | 88% Sell |
| Last Month's Opinion | 16% Sell | 40% Buy | 88% Sell | 56% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.15% since 04/19/24 | +0.33% since 04/19/24 | -1.93% since 04/19/24 | +1.02% since 04/19/24 | +6.31% since 04/19/24 |
| Low | 1.9250 on 04/26/24 | 265.72 on 04/26/24 | 64.63 on 04/26/24 | 393.00 on 04/25/24 | 192.75 on 04/23/24 |
| High | 2.3600 on 04/23/24 | 274.86 on 04/24/24 | 67.90 on 04/25/24 | 406.86 on 04/23/24 | 206.91 on 04/26/24 |
| 1-Month | |||||
| %Chg | -20.70% since 03/26/24 | -4.24% since 03/26/24 | -9.58% since 03/26/24 | -4.82% since 03/26/24 | -2.53% since 03/26/24 |
| Low | 1.8201 on 04/18/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 2.7180 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 421.45 on 04/01/24 | 217.57 on 03/28/24 |
| 3-Month | |||||
| %Chg | +6.32% since 01/26/24 | -13.46% since 01/26/24 | -17.67% since 01/26/24 | -7.41% since 01/26/24 | -15.59% since 01/26/24 |
| Low | 1.4200 on 02/06/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 3.7250 on 03/05/24 | 329.72 on 02/05/24 | 80.00 on 01/29/24 | 448.40 on 01/30/24 | 251.99 on 01/31/24 |
| 6-Month | |||||
| %Chg | -10.00% since 10/26/23 | +0.04% since 10/26/23 | -16.60% since 10/26/23 | +10.25% since 10/26/23 | -14.28% since 10/26/23 |
| Low | 1.4200 on 02/06/24 | 249.70 on 10/31/23 | 64.63 on 04/26/24 | 341.90 on 11/16/23 | 189.44 on 04/19/24 |
| High | 3.7250 on 03/05/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 | 268.30 on 01/03/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 102,162 | 144,488,960 | 81,266,176 | 102,789,152 | 29,429,788 |
| Shares Outstanding, K | 52,391 | 536,376 | 1,245,077 | 258,459 | 145,361 |
| Annual Sales | 1,049,300,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 9,835,600,000 |
| Annual Net Income | -760,500,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 1,161,100,000 |
| Last Quarter Sales | 275,800,000 | 8,196,000,000 | 7,114,000,000 | 2,517,700,000 | 2,386,300,000 |
| Last Quarter Net Income | -52,800,000 | 767,000,000 | 1,429,000,000 | 968,800,000 | 249,700,000 |
| 60-Month Beta | 1.20 | 0.58 | 0.19 | 0.35 | -0.02 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.77 on 03/06/24 | 4.71 on 02/06/24 | -1.32 on 04/25/24 | 4.20 on 02/05/24 | 3.67 on 04/24/24 |
| Latest Earnings Date | 05/01/24 | 05/02/24 | 04/25/24 | 05/06/24 | 04/24/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.64 | 9.98 | 29.82 | 13.47 |